On December 23, 2025, Dyadic International, Inc. amended its Senior Secured Convertible Promissory Notes due March 8, 2027, extending their maturity date to December 31, 2027, changing the conversion ...

Manufacture of multiple Dyadic-origin products by Fermbox Bio , enabling efficient production and market expansion of sustainable, animal-free proteins and enzymes. Dual-Sourcing flexibility, allowing ...

Dyadic Applied BioSolutions (“Dyadic”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes across life science, food & nutrition, and ...

DYAI READ THE FULL DYAI RESEARCH REPORT In the weeks following its third quarter 2025 results, Dyadic Applied BioSolutions, Inc. (NASDAQ:DYAI) announced several new partnerships and partnership ...

The agreement also allows both parties to incorporate products developed on Fermbox Bio’s microbial platforms into the joint portfolio.

Dyadic International's fair value estimate has held steady at $5.67 per share, even as the discount rate has risen slightly from 7.04% to 7.20%. This adjustment reflects a blend of optimism about ...

Dyadic International said today it will sell its industrial technology business to DuPont’s Industrial Biosciences business for $75 million cash, in a deal that will reposition the seller exclusively ...

Dyadic International Inc. ((DYAI)) has held its Q3 earnings call. Read on for the main highlights of the call. In a recent earnings call, Dyadic International Inc. showcased both achievements and ...

Dyadic International, Inc. has announced a leadership change, appointing Joe Hazelton as President to enhance its strategy of focusing on ancillary recombinant protein products for life sciences, ...

Infants' abilities to focus attention on objects are known to be related to mothers' mobilizing behaviors. As delayed effects of maternal behaviors at 5 months may be observed in 8-month-olds, mothers ...